Research
Congratulations on receiving an Arthritis Foundation research grant!
Go to this section to read policies and get the forms you need.
For more on the latest advances made by Arthritis Foundation-funded researchers, highlights of our funding program and profiles of Foundation-funded scientists, visit Research Update.
In the May/June issue:
Humira Approved for JRA
The FDA has approved adalimumab (Humira) as a treatment for the symptoms of moderate to severe juvenile rheumatoid arthritis (JRA) in patients age 4 and older.
Read more about new drugs on the horizon.